secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oncology Institute, Inc. (TOI)
CIK:        0001799191
Form:       8-K
Filed at:   2026-01-07T23:59:59+00:00
Accession:  0001079973-26-000051
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TOI appoints Mark Stolper to Board as Audit Committee Chairman
--------------------------------------------------------------

- Mark D. Stolper appointed to Board effective Jan 2, 2026; fills a vacancy.
- Stolper is CFO of RadNet (RDNT) with prior oncology board experience.
- Appointed Audit Committee Chairman and designated financial expert.
- Will receive $75,000 annual retainer and future RSU grant for board service.
- Term expires at next annual meeting; expected to be nominated for re-election.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1799191/000107997326000051/0001079973-26-000051-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1799191/000107997326000051/toi_8k.htm
  HTML page:      https://secwatch.observer/filing/0001079973-26-000051

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer